You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR SKLICE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for SKLICE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03257943 ↗ A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5% Completed Taro Pharmaceuticals USA Phase 1 2017-03-20 A Multi-Center, Double-Blind, Randomized, Placebo controlled, Parallel-group study, comparing Ivermectin Lotion, 0.5%
NCT03301649 ↗ Clinical Endpoint Study of Ivermectin 0.5% Lotion Completed Teva Pharmaceuticals USA Phase 3 2017-10-07 This clinical study is designed to evaluate the clinical (therapeutic) effect of a generic ivermectin lotion 0.5% (Actavis Laboratories UT, Inc.) relative to that of the Food and Drug Administration (FDA) Reference Listed Drug (RLD) SKLICE® (ivermectin) lotion, 0.5% (Arbor Pharmaceuticals, LLC) in participants with active head lice infestation. Additionally, both the test and reference (that is; the RLD) treatments were tested for superiority to a placebo.
NCT03301649 ↗ Clinical Endpoint Study of Ivermectin 0.5% Lotion Completed Actavis Inc. Phase 3 2017-10-07 This clinical study is designed to evaluate the clinical (therapeutic) effect of a generic ivermectin lotion 0.5% (Actavis Laboratories UT, Inc.) relative to that of the Food and Drug Administration (FDA) Reference Listed Drug (RLD) SKLICE® (ivermectin) lotion, 0.5% (Arbor Pharmaceuticals, LLC) in participants with active head lice infestation. Additionally, both the test and reference (that is; the RLD) treatments were tested for superiority to a placebo.
NCT03337490 ↗ A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice Completed bioRASI, LLC Phase 3 2017-10-02 This is a phase 3 randomized, multi-center, double-blind, placebo controlled, parallel group design study.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for SKLICE

Condition Name

Condition Name for SKLICE
Intervention Trials
Head Lice 2
COVID-19 1
Lice; Head Lice 1
Metastatic Triple-Negative Breast Carcinoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for SKLICE
Intervention Trials
Lice Infestations 3
Breast Neoplasms 1
COVID-19 1
Triple Negative Breast Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for SKLICE

Trials by Country

Trials by Country for SKLICE
Location Trials
United States 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for SKLICE
Location Trials
California 2
Florida 2
Maryland 1
Washington 1
Tennessee 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for SKLICE

Clinical Trial Phase

Clinical Trial Phase for SKLICE
Clinical Trial Phase Trials
Phase 3 2
Phase 2 2
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for SKLICE
Clinical Trial Phase Trials
Completed 3
Not yet recruiting 1
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SKLICE

Sponsor Name

Sponsor Name for SKLICE
Sponsor Trials
bioRASI, LLC 2
City of Hope Medical Center 1
Taro Pharmaceuticals USA 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for SKLICE
Sponsor Trials
Industry 6
Other 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.